Clinical conundrum; double data; mission control
Some say a focus on basic neuroscience is crushing clinical research, a gene database gets a big upgrade, and Autism Speaks revises its goals.
From funding decisions to scientific fraud, a wide range of societal factors shape autism research.
Some say a focus on basic neuroscience is crushing clinical research, a gene database gets a big upgrade, and Autism Speaks revises its goals.
It’s been 50 years since the first description of Rett syndrome, a hodgepodge of supplements sickens a boy with autism, and gender stereotypes make it hard to spot girls on the spectrum.
The presidential candidates sound off on science, dogs may hold clues about social behavior in people, and gender matters when it comes to reference letters for postdocs.
A group of savvy parents jump-started autism research in California, but they also set the research agenda.
Despite ethical concerns, watching how human neurons develop in the mouse brain could help scientists understand conditions such as autism.
Non-white adults with autism may feel forgotten, names on papers may bias peer reviewers, and eLife will begin charging publication fees.
Some parents are starting ‘N-of-1’ studies for autism, but their efforts don’t always get taken seriously.
Mark Zuckerberg and Priscilla Chan pledge $3 billion to treat disease, new rules require researchers to share clinical trial results, and neuroscientists unite for big brain projects.
Many parents resort to unproven — even dangerous — alternative treatments for their children’s autism. What drives them?
A new study shows that women with autism are continually misunderstood, work to camouflage their true selves and face a high risk of sexual abuse.